Mitochondria-targeted antioxidant attenuates high glucose-induced P38 MAPK pathway activation in human neuroblastoma cells

Cao,Mingfeng; Jiang,Jinjiao; Du,Yifeng; Yan,Peng

doi:10.3892/mmr.2012.746

Mitochondria-targeted antioxidant attenuates high glucose-induced P38 MAPK pathway activation in human neuroblastoma cells

Authors:
- Mingfeng Cao
- Jinjiao Jiang
- Yifeng Du
- Peng Yan
View Affiliations

Affiliations: Department of Endocrinology Provincial Hospital Affiliated to Shandong University, Jinan 250021, P.R. China, Department of Neurology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, P.R. China
Published online on: January 9, 2012 https://doi.org/10.3892/mmr.2012.746
Pages: 929-934

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Excessive mitochondrial free radical production and the related mitogen-activated protein kinase P38 (P38 MAPK) activation are key regulators in the pathogenesis of high glucose-induced cell stress. Increasing evidence has emphasized the impact of hyperglycemia on neurons and the consequent neuronal stresses eventually resulting in neurodegeneration and neuronal death. In this study, we employed a novel mitochondria-targeted antioxidant, SS31 peptide, on high glucose-insulted neuroblastoma cells (SH-SY5Y). Our results showed that high glucose promoted significantly increased P38 phosphorylation which was efficiently suppressed by the application of the SS31 peptide under the experimental conditions. The inhibition of high glucose-induced P38 activation by the SS31 peptide was associated with the impact of the SS31 peptide on attenuating high glucose-induced mitochondrial ROS (reactive oxygen species) elevation and mitochondrial membrane potential collapse. The addition of SS31 peptide significantly attenuated high-gluose-induced apoptosis. Therefore, our study suggests that elimination of high glucose-induced mitochondrial oxidative stress helps to rescue SH-SY5Y cells from high glucose-related P38 MAPK pathway disturbances, and the SS31 peptide has the potential to serve as a new treatment strategy against hyperglycemia-instigated neuronal perturbations.

View Figures

View References

1	F DasN DeyB VenkatesanBS KasinathN Ghosh-ChoudhuryGG ChoudhuryHigh-glucose upregulation of early-onset Parkinson's disease protein DJ-1 integrates the PRAS40/TORC1 axis to mesangial cell hypertrophyCell Signal2313111319201121426932
2	T MatsuzakiK SasakiY TanizakiInsulin resistance is associated with the pathology of Alzheimer disease: the Hisayama studyNeurology75764770201010.1212/WNL.0b013e3181eee25f20739649
3	J LiX ChenW XiaoMitochondria-targeted antioxidant peptide SS31 attenuates high-glucose-induced injury on human retinal endothelial cellsBiochem Biophys Res Commun404349356201110.1016/j.bbrc.2010.11.12221134355
4	M SchiffS LoublierA CoulibalyP BenitHO de BaulnyP RustinMitochondria and diabetes mellitus: untangling a conflictive relationship?J Inher Metab Dis32684698200910.1007/s10545-009-1263-019821144
5	JA HerleinBD FinkWI SivitzSuperoxide production by mitochondria of insulin-sensitive tissues: mechanistic differences and effect of early diabetesMetabolism59247257201010.1016/j.metabol.2009.07.02119765776
6	HL WangAH ChouAS WuPARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neuronsBiochimic Biophys Acta1812674684201110.1016/j.bbadis.2011.03.00721421046
7	J RavindranN GuptaM AgrawalAS Bala BhaskarPV Lakshmana RaoModulation of ROS/MAPK signaling pathways by okadaic acid leads to cell death via mitochondrial-mediated caspase-dependent mechanismApoptosis16145161201110.1007/s10495-010-0554-021082355
8	N BegumL RagoliaHigh-glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via P38 MAPK activationAm J Physiol Cell Physiol278C81C91200010644515
9	Y RenY ShiY WangP38 MAPK pathway is involved in high-glucose-induced thioredoxin interacting protein induction in mouse mesangial cellsFEBS Lett58434803485201010.1016/j.febslet.2010.07.01020624390
10	EA CarterAA BonabJ GovermanEvaluation of the antioxidant peptide SS31 for treatment of burn-induced insulin resistanceInt J Mol Med28589594201121805045
11	TP ReddyM ManczakMJ CalkinsToxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31Inter J Environ Res Public Health8203221201110.3390/ijerph801020321318024
12	DC AnderssonJ FauconnierT YamadaMitochondrial production of reactive oxygen species contributes to the beta-adrenergic stimulation of mouse cardiomycytesJ Physiol58917911801201110.1113/jphysiol.2010.20283821486840
13	M ManczakP MaoMJ CalkinsMitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neuronsJ Alzheimers Dis20Suppl 2S609S6312010
14	C TothV BrusseeC ChengDW ZochodneDiabetes mellitus and the sensory neuronJ Neuropathol Exp Neurol63561573200415217085
15	WA WilmerCL DixonC HebertChronic exposure of human mesangial cells to high-glucose environments activates the P38 MAPK pathwayKidney Int60858871200110.1046/j.1523-1755.2001.060003858.x11532081
16	A KuliszN ChenNS ChandelZ ShaoPT SchumackerMitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytesAm J Physiol Lung Cell Mol Physiol282L1324L1329200210.1152/ajplung.00326.200112003789
17	R SharmaE BurasT TerashimaHyperglycemia induces oxidative stress and impairs axonal transport rates in micePloS One5e13463201010.1371/journal.pone.001346320976160
18	M BrownleeThe pathobiology of diabetic complications: a unifying mechanismDiabetes5416151625200510.2337/diabetes.54.6.161515919781
19	F Guerrero-RomeroM Rodriguez-MoranComplementary therapies for diabetes: the case for chromium, magnesium, and antioxidantsArch Med Res36250257200510.1016/j.arcmed.2005.01.00415925015
20	AM VincentJW RussellP LowEL FeldmanOxidative stress in the pathogenesis of diabetic neuropathyEndocr Rev25612628200410.1210/er.2003-001915294884
21	S ChoHH SzetoE KimH KimAT TolhurstJT PintoA novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36J Biol Chem28246344642200710.1074/jbc.M60938820017178711